Filana Therapeutics, Inc. Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest
Filana Therapeutics, Inc. (FLNA) had Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest of $267.56 million as of 2021-09-30, per its 10-Q filed 2021-11-15.
Discontinued › Balance Sheet › Equity, Including Portion Attributable to Noncontrolling Interest
us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest · last filed 2021-11-15
- 2021-09-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $267.56M.
- 2021-06-30: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $276.48M.
- 2021-03-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $281.19M.
- 2020-12-31: Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest $92.20M.
| Period end | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest |
|---|---|
| 2021-09-30 | $267.56M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $276.48M 10-Q · filed 2021-11-15 |
| 2021-03-31 | $281.19M 10-Q · filed 2021-11-15 |
| 2020-12-31 | $92.20M 10-Q · filed 2021-11-15 |
| 2020-09-30 | $23.97M 10-Q · filed 2021-11-15 |
| 2020-06-30 | $24.18M 10-Q · filed 2021-11-15 |
| 2020-03-31 | $24.83M 10-Q · filed 2021-11-15 |
| 2019-12-31 | $22.10M 10-Q · filed 2021-11-15 |
| 2019-09-30 | $17.45M 10-Q · filed 2020-11-09 |
| 2019-06-30 | $17.82M 10-Q · filed 2020-11-09 |
| 2019-03-31 | $18.55M 10-Q · filed 2020-11-09 |
| 2018-12-31 | $19.63M 10-Q · filed 2020-11-09 |
| 2018-09-30 | $19.97M 10-Q · filed 2019-10-29 |
| 2018-06-30 | $8.55M 10-Q · filed 2019-10-29 |
| 2018-03-31 | $10.30M 10-Q · filed 2019-10-29 |
| 2017-12-31 | $9.70M 10-Q · filed 2019-10-29 |
| 2017-09-30 | $11.37M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $13.27M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $16.72M 10-Q · filed 2017-04-26 |
| 2016-12-31 | $18.64M 10-Q · filed 2017-11-01 |
| 2016-09-30 | $20.32M 10-Q · filed 2016-10-26 |
| 2015-12-31 | $29.37M 10-Q · filed 2016-10-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |